In another preeclampsia (a pregnancy-induced hypertensive disorder) study, Zhang et al. [31] showed that treatment with JTE013 reduced blood pressure, attenuated inflammatory cytokines (TNF-α, IL-1β, and IL-6) in placental tissues, and significantly enhanced VEGF levels. The gene discussed is VEGFA; the disease is preeclampsia.